BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34182519)

  • 1. High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma.
    Lin KY; Su TC; Yeh CM; Chao WR; Sung WW
    In Vivo; 2021; 35(4):2363-2368. PubMed ID: 34182519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer.
    Li SH; Tian H; Yue WM; Li L; Gao C; Li WJ; Hu WS; Hao B
    World J Surg; 2012 Mar; 36(3):623-31. PubMed ID: 22270988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-associated protein 1 expression in oral squamous cell carcinomas: correlation with metastasis and angiogenesis.
    Andishehtadbir A; Najvani AD; Pardis S; Ashkavandi ZJ; Ashraf MJ; Khademi B; Kamali F
    Turk Patoloji Derg; 2015; 31(1):9-15. PubMed ID: 25301048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
    Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
    Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance and Phenotype of MTA1 Expression in Esophageal Squamous Cell Carcinoma.
    Honjo H; Toh Y; Sohda M; Suzuki S; Kaira K; Kanai Y; Nagamori S; Oyama T; Yokobori T; Miyazaki T; Kuwano H
    Anticancer Res; 2017 Aug; 37(8):4147-4155. PubMed ID: 28739699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion.
    Kawasaki G; Yanamoto S; Yoshitomi I; Yamada S; Mizuno A
    Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1039-46. PubMed ID: 18640824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MTA1 in head and neck cancers.
    Marzook H; Deivendran S; Kumar R; Pillai MR
    Cancer Metastasis Rev; 2014 Dec; 33(4):953-64. PubMed ID: 25359583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer.
    Li SH; Wang Z; Liu XY
    World J Surg; 2009 Sep; 33(9):1876-81. PubMed ID: 19575142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTA1: a prognosis indicator of postoperative patients with esophageal carcinoma.
    Song L; Wang Z; Liu X
    Thorac Cardiovasc Surg; 2013 Sep; 61(6):479-85. PubMed ID: 22547301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
    PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma.
    Li Z; Yan T; Wu X; Zhang W; Li J; Wang L; Yang J
    J Oral Pathol Med; 2020 Nov; 49(10):1030-1036. PubMed ID: 32808339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer.
    Zhu X; Guo Y; Li X; Ding Y; Chen L
    J Thorac Oncol; 2010 Aug; 5(8):1159-66. PubMed ID: 20661085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies.
    Luo H; Li H; Yao N; Hu L; He T
    Tumour Biol; 2014 Jun; 35(6):5823-32. PubMed ID: 24599674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Expression Of ADAM 10 as a Predictor of Lymph Node Metastasis in Oral Squamous Cell Carcinoma-An Immunohistochemical Study.
    Jain R; Gosavi S; Sethia D; Trimuke A; Salunke M
    Head Neck Pathol; 2022 Dec; 16(4):1055-1062. PubMed ID: 35771404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between metastasis-associated protein (MTA) 1 and lymphatic metastasis in tonsil cancer.
    Park JO; Jung CK; Sun DI; Joo YH; Kim MS
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1329-34. PubMed ID: 21240515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer.
    Higashijima J; Kurita N; Miyatani T; Yoshikawa K; Morimoto S; Nishioka M; Iwata T; Shimada M
    Oncol Rep; 2011 Aug; 26(2):343-8. PubMed ID: 21617866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer.
    Deng X; Du L; Wang C; Yang Y; Li J; Liu H; Zhang J; Wang L; Zhang X; Li W; Zhang X; Wang S; Dong Z
    World J Surg; 2013 Apr; 37(4):792-8. PubMed ID: 23283219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma.
    Li WF; Liu N; Cui RX; He QM; Chen M; Jiang N; Sun Y; Zeng J; Liu LZ; Ma J
    J Transl Med; 2012 Apr; 10():78. PubMed ID: 22537306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.